PKC-THETA MODULATORS
Disclosed are compounds, compositions and methods for treating disease, syndromes, conditions and disorders that are affected by the modulation of PKC-theta. Such compounds are represented by Formula I, wherein the variables are defined herein. (I) L'invention concerne des composés, des composi...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
10.11.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed are compounds, compositions and methods for treating disease, syndromes, conditions and disorders that are affected by the modulation of PKC-theta. Such compounds are represented by Formula I, wherein the variables are defined herein. (I)
L'invention concerne des composés, des compositions et des procédés pour traiter une maladie, des syndromes, des états et des troubles qui sont affectés par la modulation de PKC-thêta. De tels composés sont représentés par la formule I, dont les variables sont définies dans la description. (I) |
---|---|
Bibliography: | Application Number: WO2022GB51166 |